Your browser doesn't support javascript.
loading
Serological Markers of Exposure to Plasmodium falciparum and Plasmodium vivax Infection in Southwestern Ethiopia.
Jeang, Brook; Lee, Ming-Chieh; Embury, Paula; Yewhalaw, Delenasaw; Narum, David; King, Christopher; Tham, Wai-Hong; Kazura, James; Yan, Guiyun; Dent, Arlene.
Affiliation
  • Jeang B; Program in Public Health, University of California Irvine, Irvine, California.
  • Lee MC; Program in Public Health, University of California Irvine, Irvine, California.
  • Embury P; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio.
  • Yewhalaw D; School of Medical Laboratory Sciences, Faculty of Health Sciences, Jimma University, Jimma, Ethiopia.
  • Narum D; Tropical and Infectious Diseases Research Center, Jimma University, Jimma, Ethiopia.
  • King C; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Tham WH; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio.
  • Kazura J; Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Yan G; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
  • Dent A; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio.
Am J Trop Med Hyg ; 108(5): 871-881, 2023 05 03.
Article in En | MEDLINE | ID: mdl-37037443
ABSTRACT
As malaria control and elimination efforts ramp up in Ethiopia, more sensitive tools for assessing exposure to coendemic Plasmodium falciparum and Plasmodium vivax are needed to accurately characterize malaria risk and epidemiology. Serological markers have been increasingly explored as cost-effective tools for measuring transmission intensity and evaluating intervention effectiveness. The objectives of this study were to evaluate the efficacy of a panel of 10 serological markers as a proxy for malaria exposure and to determine underlying risk factors of seropositivity. We conducted cross-sectional surveys in two sites of contrasting malaria transmission intensities in southwestern Ethiopia Arjo in Oromia Region (low transmission) and Gambella in Gambella Regional State (moderate transmission). We measured antibody reactivity against six P. falciparum (AMA-1, CSP, EBA175RIII-V, MSP-142, MSP-3, RH2ab) and four P. vivax (DBPII[Sal1], EBP2, MSP-119, RBP2b) targets. We used mixed effects logistic regressions to assess predictors of seropositivity. Plasmodium spp. infection prevalence by quantitative polymerase chain reaction was 1.36% in Arjo and 10.20% in Gambella. Seroprevalence and antibody levels against all 10 antigens were higher in Gambella than in Arjo. We observed spatial heterogeneities in seroprevalence across Arjo and smaller variations across Gambella. Seroprevalence in both sites was lowest against PfCSP and highest against PfAMA-1, PfMSP-142, and PvMSPS-119. Male sex, age, and agricultural occupation were positively associated with seropositivity in Arjo; associations were less pronounced in Gambella. Our findings demonstrate that seroprevalence and antibody levels to specific Plasmodium antigens can be used to identify high-risk groups and geographical areas where interventions to reduce malaria transmission should be implemented.
Subject(s)

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 3_ND Database: MEDLINE Main subject: Malaria, Vivax / Malaria, Falciparum / Malaria Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: Africa Language: En Journal: Am J Trop Med Hyg Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 3_ND Database: MEDLINE Main subject: Malaria, Vivax / Malaria, Falciparum / Malaria Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: Africa Language: En Journal: Am J Trop Med Hyg Year: 2023 Document type: Article